Related Experiment Video

Updated: Jul 12, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.5K

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis

Long Xu1,2, Xiaoyu Yan1, Jian Wang1

  • 1Key Laboratory of Pathobiology, Department of Pathophysiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, 126 Xinmin Street, Changchun 130021, China.

International Journal of Molecular Sciences
|October 28, 2023
PubMed

Insights

Histone deacetylases (HDACs) are implicated in ovarian cancer metastasis. Targeting HDACs shows promise for future ovarian cancer therapies by inhibiting cancer spread.

Area of Science:

  • Gynecologic Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Ovarian cancer is a lethal gynecologic malignancy where metastasis is the primary cause of death.
  • Metastasis in ovarian cancer is driven by complex genetic and epigenetic regulatory mechanisms.
  • Histone deacetylases (HDACs) are enzymes involved in gene transcription and protein function, with aberrant expression common in ovarian cancer.

Purpose of the Study:

  • To provide an overview of ovarian cancer metastasis.
  • To discuss the dysregulated expression of HDACs in ovarian cancer.
  • To explore the role of HDACs in regulating ovarian cancer metastasis and their therapeutic potential.

Main Methods:

  • Literature review of ovarian cancer metastasis.
  • Analysis of the role of histone deacetylases (HDACs) in cancer progression.
  • Review of HDAC-targeting compounds for therapeutic development.

Main Results:

  • HDACs play a significant role in regulating key events of ovarian cancer metastasis, including cell migration, invasion, and epithelial-mesenchymal transition.
  • Dysregulated expression of HDACs is frequently observed in ovarian cancer patients.
  • HDACs regulate gene transcription and non-histone protein functions critical for metastasis.

Conclusions:

  • Histone deacetylases (HDACs) are critical regulators of ovarian cancer metastasis.
  • Targeting HDACs represents a promising therapeutic strategy for managing ovarian cancer.
  • Development of HDAC-targeting compounds is crucial for advancing ovarian cancer treatment.
Keywords:
histone deacetylase inhibitorshistone deacetylasesmetastasisovarian cancer

More Related Videos

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.6K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.6K

Related Concept Videos

Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K